RaQualia Pharma Inc.

RaQualia Pharma Inc.verified

4579.T

Price:

$1129

Market Cap:

$27.61B

RaQualia Pharma Inc. engages in the research and development of pharmaceutical compounds worldwide. Its human products portfolio includes tegoprazan for gastroesophageal reflux disease, which is in phase 1 clinical trial in the United States; and grapiprant for pain management, which is in phase II clinical trial in the United States and phase I clinical trial in China, as well as in phase I clinical trial in China and the United States to treat cancer. The company also provides veterinary products such as, grapiprant for osteoarthritis in dogs; ghrelin receptor agonist to treat cancer-related anorexia/cachexia syndrome, and constipation resulting from spinal cord injury; and ELURA, a drug f...[Read more]

Industry

Biotechnology

IPO Date

2011-07-20

Stock Exchange

JPX

Ticker

4579.T

The Enterprise Value as of December 2025 (TTM) for RaQualia Pharma Inc. (4579.T) is 27.39B

According to RaQualia Pharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 27.39B. This represents a change of 164.14% compared to the average of 10.37B of the last 4 quarters.

RaQualia Pharma Inc. (4579.T) Historical Enterprise Value (quarterly & annually)

How has 4579.T Enterprise Value performed in the past?

The mean historical Enterprise Value of RaQualia Pharma Inc. over the last ten years is 18.30B. The current 27.39B Enterprise Value has changed 14.86% with respect to the historical average. Over the past ten years (40 quarters), 4579.T's Enterprise Value was at its highest in in the December 2017 quarter at 45.02B. The Enterprise Value was at its lowest in in the December 2015 quarter at 4.27B.

Quarterly (TTM)
Annual

Average

18.30B

Median

19.94B

Minimum

3.51B

Maximum

43.38B

RaQualia Pharma Inc. (4579.T) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of RaQualia Pharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 622.47%

Maximum Annual Enterprise Value = 43.38B

Minimum Annual Increase = -53.27%

Minimum Annual Enterprise Value = 3.51B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20248.62B-25.14%
202311.52B-48.54%
202222.38B0.40%
202122.29B13.73%
202019.60B-22.94%
201925.44B25.50%
201820.27B-53.27%
201743.38B622.47%
20166.00B71.05%
20153.51B-20.00%

RaQualia Pharma Inc. (4579.T) Average Enterprise Value

How has 4579.T Enterprise Value performed in the past?

The current Enterprise Value of RaQualia Pharma Inc. (4579.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

14.17B

5-year avg

16.88B

10-year avg

18.30B

RaQualia Pharma Inc. (4579.T) Enterprise Value vs. Peers

How is 4579.T’s Enterprise Value compared to its peers?

RaQualia Pharma Inc.’s Enterprise Value is greater than NANO MRNA Co.,Ltd. (9.42B), greater than MediciNova, Inc. (42.55M), greater than CellSeed Inc. (7.84B), greater than Japan Medical Dynamic Marketing, Inc. (14.42B), greater than Kidswell Bio Corporation (9.47B), greater than CanBas Co., Ltd. (12.74B), greater than Stella Pharma Corporation (6.42B), greater than Techno Medica Co., Ltd. (5.59B), greater than Daiken Medical Co., Ltd. (11.94B), greater than Chiome Bioscience Inc. (6.34B),

Build a custom stock screener for RaQualia Pharma Inc. (4579.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RaQualia Pharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RaQualia Pharma Inc. (4579.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RaQualia Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is RaQualia Pharma Inc.'s Enterprise Value?

What is the highest Enterprise Value for RaQualia Pharma Inc. (4579.T)?

What is the 3-year average Enterprise Value for RaQualia Pharma Inc. (4579.T)?

What is the 5-year average Enterprise Value for RaQualia Pharma Inc. (4579.T)?

How does the current Enterprise Value for RaQualia Pharma Inc. (4579.T) compare to its historical average?